| ²é¿´: 11055 | »Ø¸´: 387 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
l1409358961
|
[É̼ҹ©Ó¦]
EGM-2ÅàÑø»ù-LONZAϸ°ûÅàÑø»ù
|
||
|
ÏÞÁ¿ x ÕÅ
Âú x ¿ÉʹÓã»ÓÐЧÆÚ x Ì죻¹ýÆÚ¿ÉÍË |
ÄÚÈÝ
![]() ²úÆ·Ãû³Æ£ºEGM-2ÅàÑø»ù lonza ²úÆ·¹æ¸ñ£ºkit CC-3162 EGM-2 BulletKit (CC-3156 & CC-4176) CC-3156 EBM-2 Basal Medium 500 ml CC-4176 EGM-2 SingleQuot Kit Suppl. & Growth Factors CC-3202 EGM-2 MV BulletKit (CC-3156 & CC-4147) CC-3156 EBM-2 Basal Medium 500 ml CC-4147 EGM-2 MV SingleQuot Kit Suppl. & Growth Factors Clonetics ® EGM®-2 Endothelial Cell Growth Medium-2 is an enhancement of EGM®Medium. BBE has been removed and there has been further optimization of the basal media. Final concentration of FBS is 2%. Clonetics® Media Products are specially designed to support the growth of human and animal primary derived cells. Media systems have been specifically developed and optimized for various cell systems. Media are supplied in several formats: Basal Medium- contains no growth factors cytokines, or supplements SingleQuots® Kit - growth factors, cytokines, and supplements BulletKit ® - basal medium and SingleQuots® Kit packaged together ±ÏÌØ²©ÉúÎïÌṩµÄ EGM-2ÅàÑø»ù LONZAÆ·ÅÆÐÔÄÜ׿Խ£¬²úÆ·EGM-2ÅàÑø»ù LONZA¹«Ë¾ÒÔÆäÓÅÐãµÄÆ·ÖÊ Âú×ãÄú²»Í¬ÊµÑéµÄ¶àÖÖÐèÇó¡£ ±ÏÌØ²©ÉúÎïÌṩµÄ EGM-2 MVÅàÑø»ùÐÔÄÜ׿Խ£¬²úÆ· EGM-2 MVÅàÑø»ù LONZA¹«Ë¾ÒÔÆäÓÅÐãµÄÆ·ÖÊÂú×ã Äú²»Í¬ÊµÑéµÄ¶àÖÖÐèÇó¡£ Ê¼ÓÚ1994ÄêµÄ±ÏÌØ²©ÉúÎ±ÏÁúת»ùÒòhttp://www.bilong.com£©ÓÚ1994Äê¾ÍÓëLONZA£¨ÔCambrex£©ºÏ×÷£¬Ò»Ö±±»ÊÚȨ´úÀíLonza²úÆ·£¬ÊÇÖйú´ó½µÚÒ»¼ÒLONZA´úÀíÉÌ£¬±ÏÌØ²©ÉúÎïÒ»Ö±ÓëLonza¹«Ë¾Ð¯ÊÖ¿ªÍØÖйúÊг¡¹«Ë¾£¬ÏÖÒѳÉΪÉúÎï¼¼ÊõÁìÓòµÄٮٮÕß,Ò²½«Lonza¹«Ë¾µÄÀíÄî¹á³¹µ½µ×£¬´òÔìÉúÎï¼¼ÊõиÅÄî¡£ »¶ÓÀ´µçǢ̸ѡ¹º£¬¸ü¶à²úÆ·ÇëµÇ¼www.bitebo.com ±±¾©±ÏÌØ²©ÉúÎï¼¼ÊõÓÐÏÞÔðÈι«Ë¾ http://www.bitebo.com 400ÈÈÏߣº400-833-9299 µç»°£º010-82015225 13366202681 ÕÅîÚ QQ£º1050524889 ´« Õæ£º010-62015131 http://www.bitebo.com/a/gb2312/p ... 2011/0726/4576.html |
» ²ÂÄãϲ»¶
290µ÷¼ÁÉúÎï0860
ÒѾÓÐ16È˻ظ´
²ÄÁÏÓ뻯¹¤300Çóµ÷¼Á
ÒѾÓÐ39È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
²ÄÁϹ¤³ÌÈÕÓÉúÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
µ÷¼ÁÇóÊÕÁô
ÒѾÓÐ21È˻ظ´
Çóµ÷¼Á£¬985²ÄÁÏÓ뻯¹¤348·Ö
ÒѾÓÐ6È˻ظ´
266Çóµ÷¼Á£¬Ò»Ö¾Ô¸¹þ¹¤³Ìµç×ÓÐÅÏ¢£¬±¾¿Æ»ñ¶àÏî¹ú½±ºÍÊ¡½±
ÒѾÓÐ8È˻ظ´
271Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
270Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
²ÄÁϹ¤³Ì281»¹Óе÷¼Á»ú»áÂð
ÒѾÓÐ12È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
¸ÐлСľ³æµÄƽ̨£¬À´É¢½ð±Ò£¬×£Ð¡Ä¾³æÔ½À´Ô½ºÃ¡£
+2/208
ÅÊÖ¦»¨Ñ§Ôº´óÁ¿ÕÐÊÕµ÷¼Á£º²ÄÁÏ¿ÆÑ§Ó빤³Ì(ѧ˶£º0805)ºÍ²ÄÁϹ¤³Ì£¨×¨Ë¶£º0856£©¡£
+1/186
Ö£ÖÝÈËÔÚ±±¾©£¬Õæ³ÏÕÒ¶ÔÏ󣬷dzÏÎðÈÅ
+1/167
¶«±±Ê¯ÓÍ´óѧ»¯Ñ§»¯¹¤Ñ§Ôº»¹ÓÐÉÙÁ¿µ÷¼ÁÃû¶î£¨»¯¹¤Ñ§Ë¶¡¢×¨Ë¶£¬»¯Ñ§¿É¿çת£©
+1/88
½õÖÝÒ½¿Æ´óѧÕÐÊÕ105500ҩѧר˶µ÷¼Á
+2/60
³¤ÆÚÕÐÊÕ˶ʿѧÉú
+1/43
¿¼ÑÐ µ÷¼Á ´óÁ¬´óѧ ÁùÅÌˮʦ·¶Ñ§Ôº
+1/42
´óÁ¬´óѧ »¯Ñ§×¨Òµ ÕÐÊÕ26Äê˶ʿÑо¿Éúµ÷¼Á
+1/11
ÖØÇìÈýÏ¿¿Æ¼¼´óѧÎïÀíµç×Óѧרҵ½ÓÊÕµ÷¼Á£¬¿¼Êý¶þ¿Éµ÷£¬ÏµÍ³¿ªÖÁ4ÔÂ10ÈÕ£¬ÕýÔÚ±¨Ãû
+1/11
ºþÄÏÀí¹¤´óѧµ÷¼ÁϵͳÒÑ¿ª¡£ »¯Ñ§¡¢»¯¹¤¡¢²ÄÁÏ»¯¹¤ µ÷¼ÁÖ¸±ê³ä×㣬¼ȡÂʸߣ¬»¶Óµ÷¼Á
+1/10
ÖпÆÔºÀí»¯ËùÈÈÉùÈÈ»úÍŶÓÕÐÆ¸µçÆø¹¤³Ìרҵ(µç»ú·½Ïò)²©Ê¿ºó/ÌØ±ðÑо¿ÖúÀí
+1/10
̫ԿƼ¼´óѧ¹âѧ¹¤³Ì¡¢¹âµçÐÅÏ¢¹¤³Ì½ÓÊܵ÷¼Á
+1/8
ɽ¶«´óѧлÓñÉú¿ÎÌâ×é-³ÏƸ²©Ê¿ºó/¿ÆÑÐÖúÀí£¨³¤ÆÚÓÐЧ£©
+1/8
Ìì½òÉÌÒµ´óѧÉúÎï¼¼ÊõÓëʳƷ¿ÆÑ§Ñ§Ôº083200£»086000רҵµ÷¼ÁÕÐÉú
+1/7
¶þ´Îµ÷¼ÁÃû¶î13Ãû£¬»ª±±Àí¹¤´óѧ¿óÎï¼Ó¹¤¹¤³Ì·½Ïò½ÓÊÕµ÷¼ÁÑо¿Éú
+1/7
Postdoc position in continuum mechanics of brain tissue at KTH in Stockholm
+1/5
Î÷ÄϿƼ¼´óѧ¹ú¼ÒÖØµãʵÑéÊÒÀîÀÏʦ¿ÎÌâ×é½ÓÊÕ²ÄÁÏ¡¢»¯Ñ§ºÍ»¯¹¤ÀàÑо¿Éúµ÷¼Á
+1/4
±±¾©¸ßУ¸±Ð£³¤ÍŶÓÕÐÊÕ»úеÀ࣬»·¾³Ààѧ˶ºÍר˶
+1/4
¹óÖݲƾ´óѧ¼ÆËã»ú¿ÆÑ§Óë¼¼Êõ£¨081200£©Ñ§Ë¶½ÓÊÕµ÷¼Á
+1/4
¸£½¨Àí¹¤´óѧ²ÄÁÏѧԺÕÐÊÕרҵ´úÂë08¿ªÍ·Ñ§ÊõÐÍ˶ʿÑо¿Éú
+1/2
|
d [ ·¢×ÔСľ³æ¿Í»§¶Ë ] |
331Â¥2015-08-13 09:15:33
¡ï
l1409358961(½ð±Ò+1): лл²ÎÓë
l1409358961(½ð±Ò+1): лл²ÎÓë
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
3Â¥2015-03-20 08:50:06

ÒÑÈëפСľ³æ



»Ø¸´´ËÂ¥